Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscular Dystrophy, Duchenne and Becker Types”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Not applicableLooking for participantsNCT06539169
What this trial is testing

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Who this might be right for
Alpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more
xCures 1,000
Testing effectiveness (Phase 2)Ended earlyNCT04004065
What this trial is testing

Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Expansion (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 62
Not applicableLooking for participantsNCT07515235
What this trial is testing

DMD Gene Variants and Cardiac Dysfunction in Young Males With Dystrophinopathies

Who this might be right for
Duchenne Muscular Dystrophy (DMD)Becker Muscular DystrophyCardiomyopathy
Aristotle University Of Thessaloniki 65
Testing effectiveness (Phase 2)Study completedNCT03769116
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)

Who this might be right for
Muscular Dystrophy, Duchenne
Sarepta Therapeutics, Inc. 41
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableLooking for participantsNCT06363357
What this trial is testing

The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular Disorder

Who this might be right for
Muscular Dystrophy, DuchenneOrthotic DevicesUpper Extremity+6 more
Seoul National University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02286947
What this trial is testing

Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy

Who this might be right for
Muscular Dystrophy, Duchenne
Sarepta Therapeutics, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT03218995
What this trial is testing

Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 15
Very early researchStudy completedNCT06594094
What this trial is testing

An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)

Who this might be right for
Duchenne Muscular Dystrophin (DMD)
HuidaGene Therapeutics Co., Ltd. 4
Not applicableWithdrawnNCT05558813
What this trial is testing

Natural History of Duchenne Muscular Dystrophy Cardiomyopathy (DMD-CMP)

Who this might be right for
Duchenne Muscular Dystrophy
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)Study completedNCT00844597
What this trial is testing

Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 19
Not applicableAvailableNCT07250737
What this trial is testing

Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping

Who this might be right for
Muscular Disorders, AtrophicMuscular DiseasesMusculoskeletal Diseases+6 more
Avidity Biosciences, Inc.
Large-scale testing (Phase 3)Study completedNCT02432885
What this trial is testing

Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial

Who this might be right for
Myocardial FibrosisMuscular Dystrophies
InCor Heart Institute 76
Not applicableStudy completedNCT02470962
What this trial is testing

Cardiac Involvement in Patients With Duchenne/Becker Muscular Dystrophy

Who this might be right for
Duchenne / Becker Muscular Dystrophy
University Children's Hospital, Zurich 59
Not applicableNot Yet RecruitingNCT06874166
What this trial is testing

Social Cognition in Dystrophinopathies and Neurodevelopmental Disorders

Who this might be right for
Duchenne / Becker Muscular DystrophyOsteogenesis Imperfecta (OI)Social Cognition
IRCCS Eugenio Medea 45
Testing effectiveness (Phase 2)Ended earlyNCT01009294
What this trial is testing

Study of Ataluren (PTC124) in Nonambulatory Participants With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD)

Who this might be right for
Duchenne Muscular DystrophyBecker Muscular Dystrophy
PTC Therapeutics 6
Large-scale testing (Phase 3)Study completedNCT01557400
What this trial is testing

Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada

Who this might be right for
Duchenne Muscular DystrophyBecker Muscular DystrophyDystrophinopathy
PTC Therapeutics 94
Testing effectiveness (Phase 2)Looking for participantsNCT07287189
What this trial is testing

Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients

Who this might be right for
Duchenne Muscular DystrophyDuchenneDMD+2 more
Satellos Bioscience, Inc. 51
Not applicableStudy completedNCT00893334
What this trial is testing

Evaluation of Limb-Girdle Muscular Dystrophy

Who this might be right for
Becker Muscular DystrophyLimb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency)Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency)+1 more
Cooperative International Neuromuscular Research Group 60
Testing effectiveness (Phase 2)Study completedNCT03375164
What this trial is testing

A Gene Transfer Therapy Study to Evaluate the Safety of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 4
Load More Results